TOKYO--(BUSINESS WIRE)--Zilliqa, a highly anticipated blockchain platform based on the technology of sharding, has announced a partnership with GB Blockchain Labs (GBBL), the blockchain arm of Global Brain, one of the largest VC firms in Japan. Zilliqa will also be part of the Global Brain Alliance Forum 2017 to be held in Tokyo on December 8.

“We are excited that such a prestigious organization like GB Blockchain Labs has decided to officially partner with Zilliqa,” said Xinshu Dong, CEO of Zilliqa. “Together, with our amazing team, advisors, and other amazing partners, we are confident that the technology we will be bringing to the world of blockchain in the coming months will be really successful.”

GB Blockchain Labs, which was recently announced to foster community driven blockchain ecosystems, is the blockchain arm of Global Brain, as one of the largest and most successful venture capital firms in Japan. Their partnership with Zilliqa represents their commitment to nurturing promising blockchain companies.

“Zilliqa is a very promising technology that could have huge impact on the world of blockchain in the coming years,” said Takashi Sano of GB Blockchain Labs. “We look forward to providing guidance to their tremendous team moving forward.”

Zilliqa’s core technology stems from research done at the National University of Singapore to solve the issue of scalability of blockchains, one of the most pressing problems facing the technology today. The new platform they have developed is based upon the technology of sharding that was originally proposed by the research team in an academic paper in 2015.

Zilliqa has already built a working platform and has recently announced that their internal testnet has reached a peak throughput of 2,488 transactions per second (TX/s). For perspective, if Zilliqa were fully operational on the same number of computer nodes as Ethereum (~22,000) their transaction rate would be over 15,000 TX/s, nearly double the average of VISA, the largest electronic payment network in the world.

Learn more at: www.zilliqa.com